Article info

Download PDFPDF
BRCA Mutation Status Is Not Associated With Increased Hematologic Toxicity Among Patients Undergoing Platinum-Based Chemotherapy for Ovarian Cancer

Authors

  1. Address correspondence and reprint requests to Joanne Kotsopoulos, PhD, Women's College Research Institute, Women's College Hospital, 76 Grenville St, 6th Floor, Room 6423, Toronto, Ontario, Canada M5S 1B2. E-mail: joanne.kotsopoulos{at}wchospital.ca.

Citation

Kotsopoulos J, Willows K, Trat S, et al
BRCA Mutation Status Is Not Associated With Increased Hematologic Toxicity Among Patients Undergoing Platinum-Based Chemotherapy for Ovarian Cancer

Publication history

  • Received May 26, 2017
  • Accepted August 28, 2017
  • First published January 1, 2018.
Online issue publication 
June 18, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.